Penile squamous cell carcinoma · line 1 · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Line of therapy | 1 |
|---|---|
| Track | local_therapy |
| Linked regimen | None |
| ID | IND-PENILE-SCC-1L-PENECTOMY-NODAL |
|---|---|
| Type | Indication |
| Status | reviewed 2026-07-11 | pending_clinical_signoff |
| Diseases | DIS-PENILE-SCC |
| Sources | SRC-EAU-PENILE-2024 |
Notes
STUB — Phase 1 (zero-content disease authoring pass). Transcribed from DIS-PENILE-SCC narrative (partial/total penectomy for T2-T4; dynamic sentinel node biopsy vs modified inguinal lymphadenectomy per cN0 vs cN+). No dedicated Surgery/Procedure entities authored for penectomy / sentinel node biopsy / inguinal lymphadenectomy (mirrors the no-regimen local_therapy pattern already used by IND-MF-EARLY-1L-SKIN-DIRECTED) — a future Surgery-entity authoring pass could formalize SUR-PENILE-PARTIAL-PENECTOMY, SUR-PENILE-TOTAL-PENECTOMY, SUR-PENILE-DSNB, and SUR-PENILE-INGUINAL-LYMPHADENECTOMY as first-class entities with IndicationPhase wiring. Requires urology co-lead signoff before clinical publication (CHARTER §6.1; dev-mode-exempted for draft merge).
Used By
Algorithms
ALGO-PENILE-SCC-1L- ALGO-PENILE-SCC-1L
Indication
IND-PENILE-SCC-1L-ORGAN-SPARING- IND-PENILE-SCC-1L-ORGAN-SPARING